$SUPG Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Astex Pharmaceuticals, Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Astex Pharmaceuticals, Inc. Get notifications about new insider transactions in Astex Pharmaceuticals, Inc for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | LACK WALTER J | Director | Option Exercise | D | 4.60 | 45,000 | 207,000 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | LACK WALTER J | Director | Option Exercise | D | 2.10 | 45,000 | 94,500 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | LACK WALTER J | Director | Option Exercise | D | 5.89 | 30,000 | 176,700 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | LACK WALTER J | Director | Option Exercise | D | 7.79 | 22,500 | 175,275 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | LACK WALTER J | Director | Sell | U | 0.00 | 457,500 | 0 | 0 | 457.5 K to 0 (-100.00 %) |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Kola Ismail | Director | Option Exercise | D | 4.60 | 20,000 | 92,000 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Kola Ismail | Director | Option Exercise | D | 2.10 | 20,000 | 42,000 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Kola Ismail | Director | Option Exercise | D | 2.94 | 50,000 | 147,000 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Kola Ismail | Director | Option Exercise | D | 0.92 | 26,192 | 24,097 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Haines Timothy | Director | Option Exercise | D | 4.60 | 32,500 | 149,500 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Haines Timothy | Director | Option Exercise | D | 2.10 | 32,500 | 68,250 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Haines Timothy | Director | Option Exercise | D | 2.94 | 50,000 | 147,000 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Goldberg Allan R | Director | Option Exercise | D | 4.60 | 20,000 | 92,000 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Goldberg Allan R | Director | Option Exercise | D | 2.10 | 20,000 | 42,000 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Goldberg Allan R | Director | Option Exercise | D | 2.92 | 833 | 2,432 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Goldberg Allan R | Director | Option Exercise | D | 2.92 | 15,000 | 43,800 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Goldberg Allan R | Director | Option Exercise | D | 1.94 | 15,267 | 29,618 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Goldberg Allan R | Director | Option Exercise | D | 2.14 | 25,000 | 53,500 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Goldberg Allan R | Director | Option Exercise | D | 3.26 | 7,500 | 24,450 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Goldberg Allan R | Director | Option Exercise | D | 2.70 | 10,204 | 27,551 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Goldberg Allan R | Director | Option Exercise | D | 1.98 | 10,000 | 19,800 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Goldberg Allan R | Director | Option Exercise | D | 1.89 | 12,658 | 23,924 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Goldberg Allan R | Director | Option Exercise | D | 2.01 | 10,000 | 20,100 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Goldberg Allan R | Director | Option Exercise | D | 4.03 | 8,621 | 34,743 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Goldberg Allan R | Director | Option Exercise | D | 5.89 | 10,000 | 58,900 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Goldberg Allan R | Director | Option Exercise | D | 3.65 | 8,889 | 32,445 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Goldberg Allan R | Director | Option Exercise | D | 3.97 | 10,000 | 39,700 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Goldberg Allan R | Director | Option Exercise | D | 4.84 | 7,500 | 36,300 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Goldberg Allan R | Director | Option Exercise | D | 4.89 | 50,000 | 244,500 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Option Exercise | D | 4.60 | 32,500 | 149,500 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Option Exercise | D | 2.92 | 833 | 2,432 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Option Exercise | D | 2.92 | 25,000 | 73,000 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Option Exercise | D | 2.14 | 35,000 | 74,900 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Option Exercise | D | 3.26 | 7,500 | 24,450 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Option Exercise | D | 5.89 | 20,000 | 117,800 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Option Exercise | D | 3.97 | 20,000 | 79,400 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Option Exercise | D | 4.84 | 15,000 | 72,600 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Option Exercise | D | 5.88 | 10,000 | 58,800 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Option Exercise | D | 7.79 | 15,000 | 116,850 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | GIRARDI THOMAS V | Director | Option Exercise | D | 4.60 | 45,000 | 207,000 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | GIRARDI THOMAS V | Director | Option Exercise | D | 2.10 | 45,000 | 94,500 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | GIRARDI THOMAS V | Director | Option Exercise | D | 2.92 | 35,000 | 102,200 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | GIRARDI THOMAS V | Director | Option Exercise | D | 2.14 | 35,000 | 74,900 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | GIRARDI THOMAS V | Director | Option Exercise | D | 1.98 | 30,000 | 59,400 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | GIRARDI THOMAS V | Director | Option Exercise | D | 2.01 | 30,000 | 60,300 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | GIRARDI THOMAS V | Director | Option Exercise | D | 5.89 | 30,000 | 176,700 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | GIRARDI THOMAS V | Director | Option Exercise | D | 3.97 | 30,000 | 119,100 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | GIRARDI THOMAS V | Director | Option Exercise | D | 4.84 | 22,500 | 108,900 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | GIRARDI THOMAS V | Director | Option Exercise | D | 5.88 | 10,000 | 58,800 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | GIRARDI THOMAS V | Director | Option Exercise | D | 7.79 | 22,500 | 175,275 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | GIRARDI THOMAS V | Director | Sell | U | 0.00 | 348,500 | 0 | 0 | 348.5 K to 0 (-100.00 %) |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Fellner Peter | Director | Option Exercise | D | 4.60 | 20,000 | 92,000 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Fellner Peter | Director | Option Exercise | D | 2.10 | 20,000 | 42,000 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Fellner Peter | Director | Option Exercise | D | 2.94 | 50,000 | 147,000 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Buckland Martin | Chief Business Offi ... | Option Exercise | D | 2.71 | 180,000 | 487,800 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Buckland Martin | Chief Business Offi ... | Option Exercise | D | 1.89 | 180,000 | 340,200 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Buckland Martin | Chief Business Offi ... | Option Exercise | D | 2.21 | 150,000 | 331,500 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Buckland Martin | Chief Business Offi ... | Option Exercise | D | 0.92 | 98,220 | 90,362 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Buckland Martin | Chief Business Offi ... | Option Exercise | D | 0.79 | 32,085 | 25,347 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Buckland Martin | Chief Business Offi ... | Option Exercise | D | 0.73 | 26,192 | 19,120 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Buckland Martin | Chief Business Offi ... | Option Exercise | D | 0.87 | 19,644 | 17,090 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Buckland Martin | Chief Business Offi ... | Option Exercise | D | 0.84 | 26,192 | 22,001 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Buckland Martin | Chief Business Offi ... | Option Exercise | D | 0.70 | 52,384 | 36,669 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Buckland Martin | Chief Business Offi ... | Sell | U | 0.00 | 5,963 | 0 | 0 | 6 K to 0 (-100.00 %) |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | MOLKENTIN MICHAEL | Chief Financial Off ... | Option Exercise | D | 2.71 | 160,000 | 433,600 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | MOLKENTIN MICHAEL | Chief Financial Off ... | Option Exercise | D | 1.89 | 160,000 | 302,400 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | MOLKENTIN MICHAEL | Chief Financial Off ... | Option Exercise | D | 2.78 | 150,000 | 417,000 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | MOLKENTIN MICHAEL | Chief Financial Off ... | Option Exercise | D | 3.23 | 110,000 | 355,300 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | MOLKENTIN MICHAEL | Chief Financial Off ... | Option Exercise | D | 1.65 | 67,500 | 111,375 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | MOLKENTIN MICHAEL | Chief Financial Off ... | Option Exercise | D | 2.35 | 96,000 | 225,600 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | MOLKENTIN MICHAEL | Chief Financial Off ... | Option Exercise | D | 5.32 | 42,750 | 227,430 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | MOLKENTIN MICHAEL | Chief Financial Off ... | Option Exercise | D | 5.10 | 60,000 | 306,000 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | MOLKENTIN MICHAEL | Chief Financial Off ... | Option Exercise | D | 4.89 | 25,000 | 122,250 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | MOLKENTIN MICHAEL | Chief Financial Off ... | Sell | U | 0.00 | 28,874 | 0 | 0 | 28.9 K to 0 (-100.00 %) |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | AZAB MOHAMMAD | Chief Medical Offic ... | Option Exercise | D | 2.71 | 300,000 | 813,000 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | AZAB MOHAMMAD | Chief Medical Offic ... | Option Exercise | D | 1.89 | 200,000 | 378,000 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | AZAB MOHAMMAD | Chief Medical Offic ... | Option Exercise | D | 2.78 | 280,000 | 778,400 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | AZAB MOHAMMAD | Chief Medical Offic ... | Option Exercise | D | 3.23 | 60,000 | 193,800 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | AZAB MOHAMMAD | Chief Medical Offic ... | Option Exercise | D | 2.58 | 260,000 | 670,800 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | AZAB MOHAMMAD | Chief Medical Offic ... | Sell | U | 0.00 | 8,753 | 0 | 0 | 8.8 K to 0 (-100.00 %) |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Jhoti Harren | President | Option Exercise | D | 2.71 | 210,000 | 569,100 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Jhoti Harren | President | Option Exercise | D | 1.89 | 210,000 | 396,900 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Jhoti Harren | President | Option Exercise | D | 2.21 | 300,000 | 663,000 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Jhoti Harren | President | Option Exercise | D | 0.92 | 111,316 | 102,411 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Jhoti Harren | President | Option Exercise | D | 0.79 | 38,633 | 30,520 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Jhoti Harren | President | Option Exercise | D | 0.68 | 65,480 | 44,526 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Jhoti Harren | President | Option Exercise | D | 0.87 | 26,192 | 22,787 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Jhoti Harren | President | Option Exercise | D | 0.84 | 8,792 | 7,385 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Jhoti Harren | President | Sell | U | 0.00 | 16,084 | 0 | 0 | 16.1 K to 0 (-100.00 %) |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | Jhoti Harren | President | Sell | U | 0.00 | 45,163 | 0 | 0 | 45.2 K to 0 (-100.00 %) |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | MANUSO JAMES S J | Chief Executive Off ... | Option Exercise | D | 4.57 | 360,000 | 1,645,200 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | MANUSO JAMES S J | Chief Executive Off ... | Option Exercise | D | 1.84 | 360,000 | 662,400 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | MANUSO JAMES S J | Chief Executive Off ... | Option Exercise | D | 3.16 | 360,000 | 1,137,600 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | MANUSO JAMES S J | Chief Executive Off ... | Option Exercise | D | 2.12 | 800,000 | 1,696,000 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | MANUSO JAMES S J | Chief Executive Off ... | Option Exercise | D | 3.12 | 360,000 | 1,123,200 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | MANUSO JAMES S J | Chief Executive Off ... | Option Exercise | D | 1.76 | 1,200,000 | 2,112,000 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | MANUSO JAMES S J | Chief Executive Off ... | Option Exercise | D | 2.00 | 360,000 | 720,000 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | MANUSO JAMES S J | Chief Executive Off ... | Option Exercise | D | 3.60 | 360,000 | 1,296,000 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | MANUSO JAMES S J | Chief Executive Off ... | Option Exercise | D | 5.06 | 1,000,000 | 5,060,000 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | MANUSO JAMES S J | Chief Executive Off ... | Option Exercise | D | 5.06 | 360,000 | 1,821,600 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | MANUSO JAMES S J | Chief Executive Off ... | Option Exercise | D | 4.87 | 200,000 | 974,000 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | MANUSO JAMES S J | Chief Executive Off ... | Option Exercise | D | 5.03 | 250,000 | 1,257,500 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | MANUSO JAMES S J | Chief Executive Off ... | Option Exercise | D | 6.10 | 250,000 | 1,525,000 | 0 | |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | MANUSO JAMES S J | Chief Executive Off ... | Sell | U | 0.00 | 70 | 0 | 0 | 70 to 0 (-100.00 %) |
Oct 16 2013 | SUPG | Astex Pharmaceutic ... | MANUSO JAMES S J | Chief Executive Off ... | Sell | U | 0.00 | 13,900 | 0 | 0 | 13.9 K to 0 (-100.00 %) |
Sep 06 2013 | SUPG | Astex Pharmaceutic ... | MANUSO JAMES S J | Chief Executive Off ... | Option Exercise | M | 5.69 | 7,500 | 42,675 | 0 | |
Sep 06 2013 | SUPG | Astex Pharmaceutic ... | MANUSO JAMES S J | Chief Executive Off ... | Buy | M | 5.69 | 7,500 | 42,675 | 13,900 | 6.4 K to 13.9 K (+117.19 %) |
Jun 27 2013 | SUPG | Astex Pharmaceutic ... | Jhoti Harren | President | Gift | G | 0.00 | 16,084 | 0 | 16,084 | 0 to 16.1 K |
Jun 27 2013 | SUPG | Astex Pharmaceutic ... | Jhoti Harren | President | Gift | G | 0.00 | 16,084 | 0 | 43,700 | 59.8 K to 43.7 K (-26.90 %) |
Jun 17 2013 | SUPG | Astex Pharmaceutic ... | Kola Ismail | Director | Option Exercise | A | 4.60 | 20,000 | 92,000 | 20,000 | |
Jun 17 2013 | SUPG | Astex Pharmaceutic ... | LACK WALTER J | Director | Option Exercise | A | 4.60 | 12,500 | 57,500 | 12,500 | |
Jun 17 2013 | SUPG | Astex Pharmaceutic ... | LACK WALTER J | Director | Option Exercise | A | 4.60 | 12,500 | 57,500 | 12,500 | |
Jun 17 2013 | SUPG | Astex Pharmaceutic ... | LACK WALTER J | Director | Option Exercise | A | 4.60 | 20,000 | 92,000 | 20,000 | |
Jun 17 2013 | SUPG | Astex Pharmaceutic ... | Haines Timothy | Director | Option Exercise | A | 4.60 | 12,500 | 57,500 | 12,500 | |
Jun 17 2013 | SUPG | Astex Pharmaceutic ... | Haines Timothy | Director | Option Exercise | A | 4.60 | 20,000 | 92,000 | 20,000 | |
Jun 17 2013 | SUPG | Astex Pharmaceutic ... | Goldberg Allan R | Director | Option Exercise | A | 4.60 | 20,000 | 92,000 | 20,000 | |
Jun 17 2013 | SUPG | Astex Pharmaceutic ... | GIRARDI THOMAS V | Director | Option Exercise | A | 4.60 | 12,500 | 57,500 | 12,500 | |
Jun 17 2013 | SUPG | Astex Pharmaceutic ... | GIRARDI THOMAS V | Director | Option Exercise | A | 4.60 | 12,500 | 57,500 | 12,500 | |
Jun 17 2013 | SUPG | Astex Pharmaceutic ... | GIRARDI THOMAS V | Director | Option Exercise | A | 4.60 | 20,000 | 92,000 | 20,000 | |
Jun 17 2013 | SUPG | Astex Pharmaceutic ... | Fellner Peter | Director | Option Exercise | A | 4.60 | 20,000 | 92,000 | 20,000 | |
Jun 17 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Option Exercise | A | 4.60 | 12,500 | 57,500 | 12,500 | |
Jun 17 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Option Exercise | A | 4.60 | 20,000 | 92,000 | 20,000 | |
May 21 2013 | SUPG | Astex Pharmaceutic ... | GIRARDI THOMAS V | Director | Option Exercise | M | 4.03 | 60,000 | 241,800 | 0 | |
May 21 2013 | SUPG | Astex Pharmaceutic ... | GIRARDI THOMAS V | Director | Option Exercise | M | 4.03 | 7,500 | 30,225 | 0 | |
May 21 2013 | SUPG | Astex Pharmaceutic ... | GIRARDI THOMAS V | Director | Option Exercise | M | 4.03 | 7,500 | 30,225 | 0 | |
May 21 2013 | SUPG | Astex Pharmaceutic ... | GIRARDI THOMAS V | Director | Buy | M | 4.03 | 75,000 | 302,250 | 348,500 | 273.5 K to 348.5 K (+27.42 %) |
May 15 2013 | SUPG | Astex Pharmaceutic ... | MANUSO JAMES S J | Chief Executive Off ... | Option Exercise | M | 4.03 | 29,500 | 118,885 | 0 | |
May 15 2013 | SUPG | Astex Pharmaceutic ... | MANUSO JAMES S J | Chief Executive Off ... | Sell | S | 5.84 | 29,500 | 172,280 | 6,400 | 35.9 K to 6.4 K (-82.17 %) |
May 15 2013 | SUPG | Astex Pharmaceutic ... | MANUSO JAMES S J | Chief Executive Off ... | Buy | M | 4.03 | 29,500 | 118,885 | 35,900 | 6.4 K to 35.9 K (+460.94 %) |
May 07 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Option Exercise | M | 2.10 | 12,500 | 26,250 | 0 | |
May 07 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Option Exercise | M | 2.10 | 20,000 | 42,000 | 0 | |
May 07 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Option Exercise | M | 2.01 | 10,000 | 20,100 | 0 | |
May 07 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Option Exercise | M | 4.03 | 21,000 | 84,630 | 0 | |
May 07 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Option Exercise | M | 4.03 | 7,500 | 30,225 | 0 | |
May 07 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Sell | S | 5.87 | 65,500 | 384,485 | 0 | 65.5 K to 0 (-100.00 %) |
May 07 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Sell | S | 5.91 | 5,500 | 32,505 | 65,500 | 71 K to 65.5 K (-7.75 %) |
May 07 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Buy | M | 2.10 | 32,500 | 68,250 | 71,000 | 38.5 K to 71 K (+84.42 %) |
May 07 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Buy | M | 2.01 | 10,000 | 20,100 | 38,500 | 28.5 K to 38.5 K (+35.09 %) |
May 07 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Buy | M | 4.03 | 28,500 | 114,855 | 28,500 | 0 to 28.5 K |
May 06 2013 | SUPG | Astex Pharmaceutic ... | MANUSO JAMES S J | Chief Executive Off ... | Option Exercise | M | 4.03 | 30,500 | 122,915 | 29,500 | |
May 06 2013 | SUPG | Astex Pharmaceutic ... | MANUSO JAMES S J | Chief Executive Off ... | Option Exercise | M | 4.03 | 7,500 | 30,225 | 0 | |
May 06 2013 | SUPG | Astex Pharmaceutic ... | MANUSO JAMES S J | Chief Executive Off ... | Sell | S | 5.87 | 38,000 | 223,060 | 6,400 | 44.4 K to 6.4 K (-85.59 %) |
May 06 2013 | SUPG | Astex Pharmaceutic ... | MANUSO JAMES S J | Chief Executive Off ... | Buy | M | 4.03 | 38,000 | 153,140 | 44,400 | 6.4 K to 44.4 K (+593.75 %) |
Apr 16 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Gift | G | 0.00 | 30,000 | 0 | 0 | 30 K to 0 (-100.00 %) |
Apr 12 2013 | SUPG | Astex Pharmaceutic ... | MOLKENTIN MICHAEL | Chief Financial Off ... | Option Exercise | M | 1.65 | 7,500 | 12,375 | 67,500 | |
Apr 12 2013 | SUPG | Astex Pharmaceutic ... | MOLKENTIN MICHAEL | Chief Financial Off ... | Buy | M | 1.65 | 7,500 | 12,375 | 26,495 | 19 K to 26.5 K (+39.48 %) |
Apr 05 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Option Exercise | M | 2.01 | 10,000 | 20,100 | 0 | |
Apr 05 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Buy | M | 2.01 | 10,000 | 20,100 | 30,000 | 20 K to 30 K (+50.00 %) |
Apr 03 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Option Exercise | M | 1.98 | 10,000 | 19,800 | 0 | |
Apr 03 2013 | SUPG | Astex Pharmaceutic ... | CASAMENTO CHARLES J | Director | Buy | M | 1.98 | 10,000 | 19,800 | 20,000 | 10 K to 20 K (+100.00 %) |